MINAPHARM Pharmaceuticals

MIPH

EGS380G1C011

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 03:30:00 03/06/2024 am IST			5-day change	1st Jan Change
213.5 ^EGP	0.00%		+6.61%	-1.92%

30/05	MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
07/04	MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023	CI

MINAPHARM Pharmaceuticals S.A.E. Reports Standalone Earnings Results for the Six Months Ended June 30, 2019

August 22, 2019

MINAPHARM Pharmaceuticals S.A.E. reported standalone earnings results for the six months ended June 30, 2019. For the six months, the company reported net profit of EGP 11,982,295 compared to EGP 39,508,279 a year ago.

Latest news about MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023	07/04	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2023	29/23/29	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Bioventure, Minapharm Pharmaceuticals and Migentra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa	30/22/30	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2022	02/22/02	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	30/21/30	CI
MINAPHARM Pharmaceuticals Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021	31/21/31	CI
MINAPHARM Pharmaceuticals Reports Standalone Earnings Results for the Six Months Ended June 30, 2021	12/21/12	CI
MINAPHARM Pharmaceuticals Announces Consolidated Earnings Results for the Quarter Ended March 31, 2021	16/21/16	CI
ProBioGen AG and MINAPHARM Pharmaceuticals Incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company	27/21/27	CI
RDIF and Minapharm Agree to Produce over 40 Million Doses of the Sputnik V Vaccine in Egypt	22/21/22	CI
MINAPHARM Pharmaceuticals Announces Audited Consolidated Earnings Results for the Year Ended Dec. 31, 2020	01/21/01	CI
Shaheer Wafik Saad El Bardisy acquired an additional 10% stake in MINAPHARM Pharmaceuticals for approximately EGP 100 million.	26/20/26	CI
Minapharm Pharmaceuticals Reports Consolidated and Standalone Earnings Results for the First Quarter Ended March 2020	29/20/29	CI
Minapharm Pharmaceuticals Announces Consolidated and Standalone Earnings Results for the First Nine Months of 2019	29/19/29	CI
MINAPHARM Pharmaceuticals S.A.E. Reports Standalone Earnings Results for the Six Months Ended June 30, 2019	22/19/22	CI
Minapharm Pharmaceuticals S.A.E. Announces Consolidated Earnings Results for the Quarter Ended March 31, 2019	02/19/02	CI
MINAPHARM Pharmaceuticals S.A.E. Announces Standalone Earnings Results for the Quarter Ended March 31, 2019	15/19/15	CI
Minapharm Pharmaceuticals Declares Cash Dividend, Payable on May 29, 2019	06/19/06	CI
Minapharm Pharmaceuticals Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018	03/19/03	CI

Chart MINAPHARM Pharmaceuticals

Duration

Period

More charts

Company Profile

Minapharm Pharmaceuticals S.A.E. specializes in developing, manufacturing and marketing prescription pharmaceutical products. The products are for the treatment of gastroenterological, ophthalmologic, cardiovascular, genetic, dermatological, orthopedic diseases, etc.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
MINAPHARM PHARMACEUTICALS	-1.92%	49.97M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.37%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.56%	22.34B
SANDOZ GROUP AG	+14.89%	15.25B
CIPLA LIMITED	+16.53%	14B
ZYDUS LIFESCIENCES LIMITED	+49.78%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-10.77%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.55%	5.49B